Prostate Cancer - Results from #28300

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) - Abstract April 6, 2011

Update on prostate brachytherapy: Long-term outcomes and treatment-related morbidity - Abstract April 6, 2011

Human papillomavirus 16 or 18 infection and prostate cancer risk: A meta-analysis - Abstract April 6, 2011

MiRNA profiles of prostate carcinoma detected by multi-platform miRNA screening - Abstract April 6, 2011

Current and emerging treatment modalities for metastatic castration-resistant prostate cancer - Abstract April 6, 2011

The new biomarkers of prostate cancer - Abstract April 6, 2011

A magnetic resonance imaging-based workflow for planning radiation therapy for prostate cancer - Abstract April 6, 2011

Contrast-ultrasound diffusion imaging for localization of prostate cancer - Abstract April 6, 2011

Cost implications of the rapid adoption of newer technologies for treating prostate cancer - Abstract April 6, 2011

Editor's Commentary - Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: A randomized controlled trial April 6, 2011

BJUI Mini Reviews - Prostate cancer immunology – an update for urologists April 6, 2011

EAU 2011 - Pelvic lymph node dissection (PLND) is performed less frequently in patients treated with minimally invasive radical prostatectomy (MIRP) - Session Highlights April 6, 2011

EAU 2011 - More extensive pelvic lymph node dissection is associated with reduced risk of cancer progression in node negative organ confined prostate cancer patients - Session Highlights April 6, 2011

Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel - Abstract April 5, 2011

Pseudohyperplastic prostatic carcinoma in simple prostatectomy - Abstract April 5, 2011

Prostate cancer in men less than the age of 50: A comparison of race and outcomes - Abstract April 5, 2011

Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources - Abstract April 5, 2011

Disruptive events in the life of prostate cancer - Abstract April 5, 2011

Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment - Abstract April 5, 2011

Dose constraint for minimizing Grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: Rectal dose-volume histogram analysis of 457 patients - Abstract April 5, 2011

Page 1416 of 1436